Search published articles


Showing 2 results for Who

Sadighi S, Tirgary F, Raafat J, Mohagheghi Ma, Safavi S, Vaziri S,
Volume 67, Issue 8 (11-2009)
Abstract

Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 Background: Diffuse large B Cell lymphoma (DLBCL) is the most common subtype of non-Hogkin lymphoma (NHL). We performed a retrospective study of patients with de novo DLBCL treated in the Medical Oncology department of Cancer Institute of Iran, Tehran to assess the clinicopathologic and immunohistochemistry correlation and prognosis of the patients.
Methods: World Health Organization (WHO) classification was used to reexamine 1470 biopsy specimens related to the years 1985-2006. After excluding five cases of T Cell large cell lymphoma, 50 Patients diagnosed as DLBCL.
Results: Median age of the patients was 45.5(20-85) years: 60% were male and 30% had primary extranodal disease. The most common extranodal sites were bone, gastrointestinal tract and Head and neck areas. The most common stages were stage II (32%), stage III (32%), stage IV (20%) and stage I (16%) retrospectively and 33% had B-symptoms. All of The Patients received chemotherapy (83% CHOP regimen) and 46% treated by radiotherapy after chemotherapy. With a mean follow up time of 32 months, median survival time was 34 (95% CI 24-40) months. Prognostic factors for survival were tumor stage, B-symptoms and early relapse (less than 6 months).
Conclusions: Our data showed the importance of Immunohistochemistry method in diagnosis of DLBCL. Although DLBCL is potentially curable with CHOP chemotherapy protocol, addition of monoclonal antibody (Anti CD20) and finding new prognostic factors to predict early relapse are clearly needed in Iran.


Elham Hoseinnezhad Zarghani, Ghazale Geraily, Mahbod Esfahani, Mostafa Farzin,
Volume 78, Issue 7 (10-2020)
Abstract

Background: Total body irradiation (TBI) is a technique that is commonly used as a part of the patient conditioning regimen before the bone marrow transplant (BMT). The purpose of this study is to introduce and implement a reasonable TBI technique on the human-like phantom in Imam Khomeini Hospital in Tehran.
Methods: The present experimental study was conducted from October 2016 to November 2017 to implement the TBI technique at the Cancer Institute of Imam Khomeini Hospital in Tehran. For this purpose, percentage depth dose, and dose rate were measured in TBI condition (i.e. SSD=310 cm, field size=40×40 cm2, gantry angle=90°, and collimator angle 45°) in homogeneous phantom. Gafchromic EBT3 films were used to measure the absorbed dose in different areas of the human like phantom at the levels of head, neck, thyroid, lung, umbilicus, pelvic, thigh, knee and leg. Phantom irradiation was performed in parallel opposed anterior-posterior geometry using an 18MV photon beam produced by Varian 2100C/D. Cerrobend blocks were used for lung protection. After analyzing the exposed films with Image J software, the dose uniformity was calculated.
Results: Dose distribution uniformity was acquired in the order of -1.01% to +11.82% relative to the prescribed dose at the umbilicus. The difference between the calculated and measured dose at the umbilicus level was -2.73%. The radiation absorbed dose to the lung with blocks was 127.53cGy in one fraction which resulted in 756.18cGy in six fractions.
Conclusion: The implemented technique, obtained the acceptable ±10% dose uniformity in most of the body regions. The dosing accuracy was within the acceptable range. The lungs¢ dose was reduced to the desired level using lung shields. This technique is a simple and cost-effective method that does not require complicated dosimetric techniques. Regarding the obtained results, the proposed technique has the necessary conditions for implementation in Imam Khomeini hospital in Tehran.
 


Page 1 from 1     

© 2026 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by : Yektaweb